Literature DB >> 8098729

Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.

R E Benson1, A Sanfridson, J S Ottinger, C Doyle, B R Cullen.   

Abstract

The nef gene product encoded by the mac239 proviral clone of simian immunodeficiency virus (SIV) markedly enhances viral replication and pathogenesis in vivo. We have used this biologically active nef isolate to examine the phenotype of Nef in retrovirally transduced human T cells in culture. SIV Nef is shown to dramatically inhibit cell-surface expression of the CD4 glycoprotein without significantly affecting the total steady-state level of cellular CD4. This downregulation of the cell-surface CD4 receptor for human immunodeficiency virus type 1 (HIV-1) infection correlated with the acquisition of resistance to superinfection by HIV-1. However, SIV Nef did not affect the level of gene expression directed by the HIV-1 long terminal repeat. It is hypothesized that downregulation of cell-surface CD4 by Nef facilitates the efficient release of infectious progeny virions and, hence, viral spread in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8098729      PMCID: PMC2191034          DOI: 10.1084/jem.177.6.1561

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  34 in total

1.  Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV.

Authors:  J A Hoxie; J D Alpers; J L Rackowski; K Huebner; B S Haggarty; A J Cedarbaum; J C Reed
Journal:  Science       Date:  1986-11-28       Impact factor: 47.728

2.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Authors:  J S Allan; J E Coligan; T H Lee; M F McLane; P J Kanki; J E Groopman; M Essex
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

3.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Use of eukaryotic expression technology in the functional analysis of cloned genes.

Authors:  B R Cullen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

5.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

6.  Effects of mutations within the 3' orf open reading frame region of human T-cell lymphotropic virus type III (HTLV-III/LAV) on replication and cytopathogenicity.

Authors:  E Terwilliger; J G Sodroski; C A Rosen; W A Haseltine
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

7.  Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones.

Authors:  B Asjö; I Ivhed; M Gidlund; S Fuerstenberg; E M Fenyö; K Nilsson; H Wigzell
Journal:  Virology       Date:  1987-04       Impact factor: 3.616

8.  Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells.

Authors:  G Franchini; M Robert-Guroff; J Ghrayeb; N T Chang; F Wong-Staal
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

9.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

10.  Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication.

Authors:  M H Malim; W W Freimuth; J Liu; T J Boyle; H K Lyerly; B R Cullen; G J Nabel
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

View more
  120 in total

Review 1.  Structure--function relationships in HIV-1 Nef.

Authors:  M Geyer; O T Fackler; B M Peterlin
Journal:  EMBO Rep       Date:  2001-07       Impact factor: 8.807

2.  A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation.

Authors:  L Alexander; Z Du; M Rosenzweig; J U Jung; R C Desrosiers
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 3.  HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.

Authors:  Alison L Greenway; Gavan Holloway; Dale A McPhee; Phoebe Ellis; Alyssa Cornall; Michael Lidman
Journal:  J Biosci       Date:  2003-04       Impact factor: 1.826

4.  A novel motif in HIV-1 Nef that regulates MIP-1beta chemokine release in macrophages.

Authors:  Lue Dai; Mario Stevenson
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

5.  The T-cell receptor zeta chain contains two homologous domains with which simian immunodeficiency virus Nef interacts and mediates down-modulation.

Authors:  T M Schaefer; I Bell; B A Fallert; T A Reinhart
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Authors:  N L Michael; G Chang; L A d'Arcy; C J Tseng; D L Birx; H W Sheppard
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4.

Authors:  S S Rhee; J W Marsh
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.

Authors:  C Aiken; D Trono
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

Review 9.  The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection.

Authors:  S Bour; R Geleziunas; M A Wainberg
Journal:  Microbiol Rev       Date:  1995-03

10.  A naturally occurring variation in the proline-rich region does not attenuate human immunodeficiency virus type 1 nef function.

Authors:  Elke Rücker; Jan Münch; Steffen Wildum; Matthias Brenner; Jutta Eisemann; Leonid Margolis; Frank Kirchhoff
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.